Full-Time

Quality Specialist

Laboratory Quality Management, Laboratory Administration Department

Posted on 10/4/2025

Deadline 9/12/26
The University of Chicago Medicine

The University of Chicago Medicine

5,001-10,000 employees

Academic medical center delivering patient care

No salary listed

Chicago, IL, USA

Hybrid

Hybrid role requiring 3 days on-site per week; travel to offsite locations (Crown Point, Orland Park).

Category
Legal & Compliance (2)
,
Requirements
  • Bachelor’s degree in clinical laboratory science or related field from an accredited college or university
  • Certification as Medical Technologist (MT, MLS), or Specialist (S__ ) through the American Society of Clinical Pathologists required
  • Must satisfy CLIA 88 qualification requirements for general supervisor who oversees testing personnel performing high complexity testing
  • Five years minimum clinical laboratory work experience required, including experience in clinical laboratory quality management activities
  • Experience in performance and evaluation of quality control procedures, preventive maintenance, trouble-shooting and calibration procedures on clinical equipment, and validation of test results required
Responsibilities
  • Supports the quality management program for the Clinical Laboratories at Hyde Park and satellite locations, including point of care testing service, in accordance with the mission and strategic goals of UCM and the regulatory/accreditation standards for the hospitals and laboratories
  • Collaborates as assigned with other Medical Center departments in specific quality and process improvement activities
  • Contributes to the development, integration and collaborative maintenance of standardized quality management systems across the Clinical Laboratories
  • Develops and implements actions required to support laboratory strategic, quality and operational goals as assigned
  • Guides and collaborates with laboratory section directors and managers in the overall preparation of Clinical Laboratories for inspections by licensing and accrediting agencies (e.g., CAP, JC, State of Illinois, IDPH, City of Chicago). Helps support and coordinate compliance for biannual accreditation and interim reviews by CAP, AABB, tJC, FDA, ASHI, State of New York, COLA and any other regulatory agency, including the registration fees, applications, actual inspections and conferences, and responses to all deficiencies.
  • Manages key software applications required for regulatory compliance including, MediaLab Document Control and Inspection Proof applications, and works with all laboratories to utilize the application for its fullest capacity
  • Develops and recommends departmental-wide policies and procedures required for regulatory compliance and optimal operations.  Works with CLIA Medical Director and other directors and managers to drive the review, approval and implementation of departmental policies and procedures
  • Manages the online Laboratory Handbook to assure accurate and complete information for all UCMC providers and UCML clients
  • Coordinates mock surveys and other audits of regulatory compliance along with follow-up consultation with laboratories to correct deficiencies following an inspection
  • Participates in UCMC mock tJC and other organization-wide surveys as assigned
  • Manages records of all inspection activities for reference as required by regulatory and accrediting bodies
  • Contributes to the development of new processes and monitors that maintain a state of readiness and compliance with regulatory standards
  • Monitors, collects, documents and communicates all changes to existing accreditation and licensing standards and ensures laboratories are prepared to respond to changes
  • Manages lab-wide proficiency testing program summary; disseminates notices of participation insufficiency or failure including non-acceptable responses; works with lab sections on response and applicable improvement processes
  • Manages water purity and pipet, assessment programs; guides lab sections thermometric device compliance program
  • Participates in inter-laboratory surveys, peer review assessments, and other QI initiatives as assigned
  • Manages collection, analysis and collation of laboratory data from laboratory and medical center information systems and applications to provide data-driven support of laboratory quality indicators, improvement initiatives and MDI huddles
  • Supports assigned projects to address issues or improve processes
  • Represents the Clinical Laboratories on institutional committees as assigned and provides reports on participation
  • Participates in UCMC OE events, meetings, and Kaizens as needed and provides reports on participation
  • Manages and provides logistical support of documents, minutes and meetings for the Labs Clinical Laboratory Quality Management meeting.  Provides additional support in collection and evaluation of data to support lab quality efforts
  • Communicates Quality Management information regarding performance improvement activities and corrective actions to Clinical Laboratories leadership and other groups as assigned
  • Receives problem and event reports, performs initial investigation and triages to both leadership and appropriate lab section for root cause investigation
  • Collects and coordinates analysis and summary of event and problem reports on a regular basis to look for trends and opportunities for additional improvement to prevent recurrence
  • Collaborates as assigned with involved areas (both inside and outside Clinical Laboratories) to address patient safety issues
  • Works with directors, managers and other laboratory leadership as assigned to develop and document feedback to care center providers as related to performance issues and adverse events
  • Audits of the tracer methodology for maintaining regulatory preparedness. Documents that corrective actions are identified, implemented and assessed
  • Analyzes and evaluates laboratory data and other information to assess methodologies, logistics and strategies designed to optimize laboratory service and utilization and correct recurring problems
  • Utilizes the Medical Center’s EMR (Epic), Laboratory Information Systems (Sunquest, CoPath, Histotrac), and other information systems as needed to respond to surveys, troubleshoot problem reports and/or patient events, quality improvement initiatives, and for statistical analysis
  • Coordinates laboratory safety progam in collaboration with UCMC Safety Office, Infection Control, Radiation Safety, Emergency Management, Business Continuity and Lab leadership to maintain compliance with federal, state and local requirements and a safe work environment for all laboratory staff
  • Serves as Chair to UCMC Laboratory Safety Committee meetings.  Works closely with laboratory safety representatives to ensure all federal, state, city, accreditation and Medical Center policies, procedures, and guidelines are adhered to in each laboratory section
  • Guides EOC rounding of laboratory spaces, collects data on observations and develops summary reports to improve Laboratory’s compliance with life-safety, infection control and public safety requirements and directives
  • Develops and collaborates with Infection Control and Radiation Safety on policies, procedures and issues related to laboratories and staff
  • Participates in UCMC Safety and Environment of Care meetings
  • Develops and supports update of Labs safety and business continuity policies and documents in both MediaLab and Sharepoint
Desired Qualifications
  • Broad understanding of Laboratory and Medicine quality performance indicators and processes
  • Broad understanding of clinical laboratory processes and workflow
  • Ability to identify measures or indicators of system performance and the actions needed to improve or correct performance, relative to the goals of the quality system
  • Ability to coordinate and lead complex projects and initiatives across all clinical laboratory sub-specialty services
  • Understanding of regulatory, accrediting and external reporting requirements as applied to hospitals and laboratories
  • Ability to develop and maintain productive working relationships with internal and external departments, staff and leadership
  • Ability to apply basic statistical concepts and methods commonly utilized in clinical laboratory science
  • Knowledge and ability to use laboratory and hospitals information systems (Epic and Sunquest applications)
  • Strong proficiency in the use of word processing, spreadsheet, and graphical computer programs
  • Demonstrated awareness of factors that influence test results
  • Ability to work independently and exercise sound judgment and experience when working with both small and large groups to complete projects
  • Strong written and verbal communication skills appropriate for the needs of the intended audience
  • Exceptional organizational ability and attention to detail mandatory and able to meet defined deadlines and timeframes including those with immediate turn-around-times
  • Knowledge of lean and six sigma methodologies and statistical process control
The University of Chicago Medicine

The University of Chicago Medicine

View

The University of Chicago Medicine provides comprehensive healthcare through its Hyde Park campus, regional facilities, and outpatient clinics, backed by the Medical Center, Pritzker School of Medicine, and the Biological Sciences Division. It offers specialized care across more than 40 institutes and centers, including an NCI-designated Comprehensive Cancer Center, with 805 licensed beds, about 850 attending physicians, around 2,500 nurses, and over 1,100 residents and fellows. Care is delivered by clinical teams in hospitals and clinics, with ongoing research and education that translate new knowledge into treatments and train the next generation of clinicians. As an academic medical center that links a hospital system with a medical school and biology division, it combines patient care, medical education, and biomedical research while serving a regional network in the Chicago area.

Company Size

5,001-10,000

Company Stage

Grant

Total Funding

$112.4M

Headquarters

Chicago, Illinois

Founded

1927

Simplify Jobs

Simplify's Take

What believers are saying

  • Artisight deployment cuts fall rates 78% and boosts on-time discharges 4x across UChicago Medicine.
  • Ralph Lauren Center expands cancer care to South Side via 2026 Ingalls launch and 2027 pavilion.
  • 24/7 Partum Health doulas enhance birth equity and satisfaction at UChicago Family Birth Center.

What critics are saying

  • Artisight's 1,800 AI devices expose UChicago Medicine to cyberattacks disrupting patient data by November 2026.
  • iMRI suite's overhyped claims without outcome data erode physician trust by November 2027.
  • Tegoprubart trial triggers graft failures, FDA halt, and Transplant Institute lawsuits by November 2026.

What makes The University of Chicago Medicine unique

  • Artisight's unified sensor platform spans patient rooms, ORs, and PACUs across 1,800 devices at UChicago Medicine.
  • First-in-Chicago PPIBD Clinic integrates gastroenterology, maternal-fetal medicine, and intestinal ultrasound for IBD pregnancies.
  • Tegoprubart trial achieves insulin independence in type 1 diabetes islet transplants without calcineurin inhibitors.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options

Tuition Reimbursement

Company News

Audacy
Mar 31st, 2026
U Chicago partners with Partum Health to staff doulas around the clock.

U Chicago partners with Partum Health to staff doulas around the clock. Partum Health doulas pose for a photo at doula training at U Chicago Medicine. Starting Tuesday, doulas are available 24/7 at UCM Birthing Center in Hyde Park. Partum Health Starting Tuesday, a team of full-spectrum doulas with Chicago-based startup Partum Health will be working around the clock alongside the doctors, midwives and nurses at the University of Chicago Medicine Family Birth Center in Hyde Park. "This is just a really exciting way that we have been able to partner to take legislation in a way that it actually touches patients and is going to be improving health equity and birth outcomes, patient satisfaction and efficiency in a hospital," said Dr. Melissa Dennis, Chief Medical Officer at Partum. She said having doulas on staff 24/7 means patients don't have to worry about pre-arranging doula support. Historically, patients would have find doulas and pay for them on their own. Partum Health "Now, what we're doing is creating an environment where, when patients show up to the family birth center, there will be a doula available to support them in labor if they have not pre-arranged to have a doula supporting them," Dr. Dennis said. Doulas are trained non-clinical professionals who offer personalized physical, emotional and informational support to patients. Dr. Dennis said research shows that when patients work with doulas, they have a better birthing experience. "Most of our doulas who we have hired are from the community or have always served the community in the South Side of Chicago and are committed to health equity and to ensuring that these voices are heard," she said. She said it's part of a larger goal where a higher standard of care is the new standard of care. "This is just a way that they have that additional support that they need to make this the safest and most joyful experience that they can have while entering to give birth," she said.

HCPLive
Mar 17th, 2026
Tegoprubart enables insulin independence in type 1 diabetes Islet Transplant study.

Tegoprubart enables insulin independence in type 1 diabetes Islet Transplant study. New data show tegoprubart enabled insulin independence and strong glycemic control in adults with long-standing type 1 diabetes undergoing islet transplantation. Eledon Pharmaceuticals has announced updated results from an investigator-initiated trial of 12 adults with long-standing type 1 diabetes undergoing allogeneic islet transplantation who received tegoprubart as part of a calcineurin inhibitor-free immunosuppression regimen. The pilot study was conducted at the University of Chicago Medicine Transplant Institute and results were presented by Piotr Witkowski, MD, PhD, director of the Pancreas and Islet Transplant Program at UChicago Medicine, at the Advanced Technologies and Treatments for Diabetes (ATTD) conference in Barcelona, Spain. "T1D patients have been waiting decades for a potential functional cure, and it is very encouraging to see meaningful progress in that direction through the emerging promise of tegoprubart," David-Alexandre Gros, MD, Chief Executive Officer of Eledon, said in a statement. "These latest findings support the potential of tegoprubart to enable effective islet graft protection while avoiding the toxicities often associated with calcineurin inhibitors, and potentially enable access to islet cell transplantation for individuals living with T1D. We are proud to contribute to these important ongoing research efforts and support the work of Dr. Witkowski and the team at UChicago Medicine. We also look forward to working closely with the FDA towards our goal of receiving regulatory guidance on a path to market for tegoprubart in islet cell transplantation later this year." Tegoprubart is a humanized monoclonal antibody that selectively inhibits CD40 ligand, a co-stimulatory molecule in T cell activation. It is being explored in preclinical and clinical studies in kidney allograft transplantation, xenotransplantation, islet cell transplantation, liver allograft transplantation and amyotrophic lateral sclerosis. In nephrology, phase 2 BESTOW trial data suggest tegoprubart provides comparable efficacy and superior safety to tacrolimus as the core immunosuppressant in de novo kidney transplant recipients. The latest study in adults with long-standing type 1 diabetes included patients undergoing allogeneic islet transplantation at UChicago Medicine. Participants had a median duration of diabetes of approximately 33 years, a mean hemoglobin A1C of approximately 8.0% prior to transplantation, and received tegoprubart as part of a calcineurin inhibitor-free immunosuppression regimen. Data presented at ATTD showed rapid improvement in glycemic control following islet transplantation, with stable islet graft function observed across the cohort. All 10 patients who were > 4 weeks post-transplant achieved both insulin independence and a most recent HbA1c < 6.0%, with a mean most recent HbA1c across the 10 patients of approximately 5.35%. Of note, tegoprubart-based immunosuppression was generally well tolerated with reported post-transplant immunosuppression-related adverse events successfully treated by lowering the mycophenolic acid dose, if necessary. There were no rejection episodes, and no patients developed de novo donor-specific HLA antibodies. Additionally, no evidence of nephrotoxicity, hypertension or neurotoxicity was observed. The UChicago Medicine-initiated clinical trial is funded by Breakthrough T1D, with additional commitment to fund a second study evaluating tegoprubart as part of a calcineurin inhibitor-free immunosuppression drug regimen to prevent islet transplant rejection in individuals with T1D and chronic kidney disease. "Breakthrough T1D is proud to fund the University of Chicago's clinical trial testing tegoprubart as a novel immunosuppression alternative for use in islet cell transplants and we are very encouraged by the early data," said Aaron Kowalski, PhD, CEO of Breakthrough T1D. "It is exciting to see islet transplant recipients in this trial who no longer need to administer insulin and who are experiencing fewer side effects than with traditional immunosuppressive regimens."

Saluda Standard-Sentinel
Mar 2nd, 2026
Chicago's Top Medical Centers Make Global Impact as Northwestern Memorial, Rush University, and University of Chicago Earn Spots on Newsweek's 2026 World's Best Hospitals List

Chicago's top medical centers make global impact as northwestern Memorial, rush University, and University of Chicago earn spots on Newsweek's 2026 World's Best Hospitals list. CHICAGO, ILLINOIS - Three of Chicago's leading hospitals have secured prestigious placements on Newsweek's 2026 "World's Best Hospitals" list, reinforcing the city's reputation as a global hub for advanced medical care and patient-centered treatment. The annual ranking, now in its eighth year, evaluated more than 2,500 hospitals worldwide and recognized the top 250 institutions for excellence in healthcare delivery, patient outcomes, and overall performance. Northwestern Memorial leads Illinois hospitals. Northwestern Memorial Hospital earned the highest ranking among Illinois hospitals, coming in at No. 61 globally. It was also the only hospital in the state to receive a PROMs ribbon - a distinction tied to Patient-Reported Outcome Measures (PROMs). PROMs evaluate how patients perceive their well-being and quality of life after treatment, offering insight into real-world recovery experiences beyond traditional clinical metrics. Rush and University of Chicago also recognized. Rush University Medical Center followed at No. 130, while University of Chicago Medical Center secured the No. 135 spot on the global list. All three institutions were evaluated using four major data sources: * Recommendations from medical professionals * Hospital quality metrics * Patient experience data * Results from Statista's PROMs survey The methodology blends expert opinion with patient feedback and measurable performance standards, aiming to provide a comprehensive look at hospital quality across the globe. How the global rankings compare. Outside of Illinois, Mayo Clinic once again claimed the No. 1 overall ranking worldwide, marking its eighth consecutive year at the top of the list. The global competition includes major academic medical centers and healthcare systems from Europe, Asia, and North America, making the inclusion of three Chicago hospitals a significant achievement for the city's healthcare landscape. Why this matters. Recognition on an international ranking like Newsweek's carries weight beyond prestige. For patients, it signals high standards of care, advanced research capabilities, and a commitment to improving long-term outcomes. Chicago's continued presence on the list highlights the strength of its healthcare institutions and their role in shaping modern medicine. Do you or your family rely on any of these hospitals? Share your experiences and thoughts with Saludastandard Sentinel at SaludaStandard-Sentinel.com.

Neurosurgery Education
Feb 3rd, 2026
New iMRI at UChicago Medicine: Technology, Narrative, and Clinical Reality

New iMRI at UChicago Medicine: technology, narrative, and clinical reality. On February 3, 2026, UChicago Medicine announced the launch of a new intraoperative MRI (iMRI) suite, presenting it as a transformative advance that makes brain surgery "safer, faster and more precise." According to the institutional report, the system enables real-time imaging during surgery, reduces operative time by up to two hours, and allows surgeons to move beyond lesion removal toward treatment guided by "disease biology." Source: New iMRI tech at UChicago Medicine makes brain surgery safer, faster and more precise (UChicago Medicine, Feb 3, 2026). From the perspective of neurosurgery.education, this announcement is best understood as a promotional narrative centered on infrastructure, rather than a clinically rigorous analysis of outcomes. What iMRI genuinely offers. There is no doubt that intraoperative MRI can be a valuable technical tool in selected neurosurgical scenarios. Its main, well-established contributions include: * Detection of residual tumor before closure * Correction of brain shift affecting neuronavigation * Reduction in the need for early re-operation in specific cases These advantages are particularly relevant in infiltrative gliomas, complex epilepsy surgery, and selected functional or vascular procedures. Used appropriately, iMRI can improve the extent of resection and intraoperative decision-making. Where the narrative overreaches. The UChicago Medicine article blurs several critical distinctions. Claims about "functional MRI in real time" and treatment based on "metabolic profiles and brain networks" suggest capabilities that go well beyond what current iMRI workflows reliably deliver in routine practice. Intraoperative MRI is, in most centers, primarily an anatomical imaging tool, not a real-time functional or metabolic decision engine. Similarly, repeated use of terms such as transformative, nation-leading, and world-class is not accompanied by: * Quantitative data on extent-of-resection improvement * Evidence of reduced morbidity or improved survival * Clear patient-selection criteria Reduced operative time is presented as a universal benefit, when in reality it is highly dependent on team experience, workflow optimization, and case selection. In many settings, iMRI initially prolongs procedures during the learning phase. Technology does not replace judgment. A central concern from an educational standpoint is the implicit substitution of technology for clinical reasoning. No imaging modality compensates for: * Incorrect surgical indication * Poor anatomical strategy * Inadequate understanding of functional boundaries An iMRI suite magnifies both strengths and weaknesses of a surgical team. In expert hands it can refine decisions; in less experienced ones, it risks adding complexity without proportional benefit. The missing discussion: cost and value. Absent from the announcement is any discussion of cost-effectiveness, resource allocation, or opportunity cost. iMRI systems require: * Dedicated architectural design * MRI-compatible instrumentation * Specialized training for the entire operating room team For many hospitals - and for many neurosurgical pathologies - these investments do not translate into meaningful clinical gain. Conclusion. The arrival of an iMRI suite at UChicago Medicine reflects a significant institutional investment and a legitimate commitment to technological advancement. However, the accompanying narrative exemplifies a broader trend in academic medicine: equating technological presence with clinical excellence. From the standpoint of neurosurgery.education, excellence is not defined by the magnet in the room, but by indication, strategy, execution, and outcome. iMRI is a powerful adjunct in carefully selected cases - but it is not, by itself, a transformation of neurosurgical care. Reference: UChicago Medicine. New iMRI tech at UChicago Medicine makes brain surgery safer, faster and more precise. February 3, 2026.

HF Chronicle
Jan 24th, 2026
UChicago Medicine to open Ralph Lauren Center at Ingalls Hospital to expand access to cancer care

UChicago Medicine to open Ralph Lauren Center at Ingalls hospital to expand access to cancer care. More in free: The Ralph Lauren Corporate Foundation has awarded a grant to the University of Chicago Medicine Comprehensive Cancer Center to establish the UChicago Medicine Ralph Lauren Center, reflecting a joint commitment to bridging gaps in cancer health and expanding cancer care in the city's vulnerable communities. The UChicago Medicine Ralph Lauren Center will offer cancer prevention, diagnosis, treatment and support services at two of the academic health system's locations, serving patients and the communities on the city's South Side and in the South Suburbs. The first site will be at UChicago Medicine Ingalls Memorial in Harvey and will launch in 2026. The other will be at the health system's main campus on the South Side within the new cancer pavilion, scheduled to open as the AbbVie Foundation Cancer Pavilion in April 2027. "We are honored that The Ralph Lauren Corporate Foundation selected UChicago Medicine to open the first Ralph Lauren Center in the Midwest and the fourth in the U.S.," said Dr. Kunle Odunsi, director of the UChicago Medicine Comprehensive Cancer Center. "The award speaks to our shared mission to improving access to cancer care in the community." The grant is part of a $25 million commitment by The Ralph Lauren Corporate Foundation to expand or establish five Ralph Lauren-named centers in communities across the United States. The funding is designed to benefit organizations that have an NCI cancer center designation, which recognizes their innovative research, leading-edge treatments, education and community-outreach programs. UChicago Medicine has been home to such a designated center since 1973. "Over the last 30 years, our mission to support communities around the world in the fight against cancer has grown into something greater than I could have ever imagined. From New York to Washington, Los Angeles and now Chicago, we are making a real impact on this disease, helping to raise awareness, improve outcomes and provide support - all thanks to the tireless work of the dedicated caregivers at our cancer centers," said Ralph Lauren, executive chairman and chief creative officer of Ralph Lauren Corporation and chair of The Ralph Lauren Corporate Foundation. Dr. Nita Lee, associate director of community outreach and engagement at UChicago Medicine Comprehensive Cancer Center, will serve as program director of the UChicago Medicine Ralph Lauren Center at both locations. To launch the program, she will work closely with UChicago Medicine's Urban Health Initiative, led by Chief Community Health Transformation Officer Catina Latham, and Ingalls Memorial oncology team, led by Director Dr. James Wallace. Cancer is a leading cause of death in Chicago's South Side and South Suburbs, where social determinants of health lead to higher cancer burdens.

INACTIVE